These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31366562)
1. Sarcomatous Component in Pancreatic Adenosquamous Carcinoma: A Clinicopathological Series of 7 Cases. Taniwaki S; Hisaka T; Sakai H; Goto Y; Nomura Y; Kawahara R; Ishikawa H; Yasunaga M; Naito Y; Akiba J; Yano H; Tanaka H; Akagi Y; Okuda K Anticancer Res; 2019 Aug; 39(8):4575-4580. PubMed ID: 31366562 [TBL] [Abstract][Full Text] [Related]
2. Increased Proportion of the Squamous Cell Carcinoma Components Is Associated with Aggressive Behavior and a Worse Prognosis in Resected Pancreatic Adenosquamous Carcinoma. Tatsuguchi T; Kitahara D; Kozono S; Date K; Shinkawa T; Kuga H; Tamiya S; Nishihara K; Nakano T J Gastrointest Cancer; 2024 Oct; 56(1):5. PubMed ID: 39422835 [TBL] [Abstract][Full Text] [Related]
3. A huge adenosquamous carcinoma of the pancreas with sarcomatoid change: an unusual case report. Lu BC; Wang C; Yu JH; Shen ZH; Yang JH World J Gastroenterol; 2014 Nov; 20(43):16381-6. PubMed ID: 25473201 [TBL] [Abstract][Full Text] [Related]
4. Surgical outcome of adenosquamous carcinoma of the pancreas. Okabayashi T; Hanazaki K World J Gastroenterol; 2008 Nov; 14(44):6765-70. PubMed ID: 19058301 [TBL] [Abstract][Full Text] [Related]
5. Genomic signatures of pancreatic adenosquamous carcinoma (PASC). Fang Y; Su Z; Xie J; Xue R; Ma Q; Li Y; Zhao Y; Song Z; Lu X; Li H; Peng C; Bai F; Shen B J Pathol; 2017 Oct; 243(2):155-159. PubMed ID: 28722109 [TBL] [Abstract][Full Text] [Related]
6. Adenosquamous carcinoma of the pancreas. Aranha GV; Yong S; Olson M Int J Pancreatol; 1999 Oct; 26(2):85-91. PubMed ID: 10597404 [TBL] [Abstract][Full Text] [Related]
7. PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component. Tanigawa M; Naito Y; Akiba J; Kawahara A; Okabe Y; Ishida Y; Ishikawa H; Hisaka T; Fujita F; Yasunaga M; Shigaki T; Sudo T; Mihara Y; Nakayama M; Kondo R; Kusano H; Shimamatsu K; Okuda K; Akagi Y; Yano H Pathol Res Pract; 2018 Dec; 214(12):2069-2074. PubMed ID: 30477643 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of adenosquamous pancreatic cancer. Regi P; Butturini G; Malleo G; Pedica F; D'Onofrio M; Bassi C Langenbecks Arch Surg; 2011 Feb; 396(2):217-22. PubMed ID: 20617336 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors. Komatsu H; Egawa S; Motoi F; Morikawa T; Sakata N; Naitoh T; Katayose Y; Ishida K; Unno M Surg Today; 2015 Mar; 45(3):297-304. PubMed ID: 24973941 [TBL] [Abstract][Full Text] [Related]
10. Adenosquamous carcinoma of the gallbladder. Kondo M; Dono K; Sakon M; Shimizu J; Nagano H; Nakamori S; Umeshita K; Wakasa K; Monden M Hepatogastroenterology; 2002; 49(47):1230-4. PubMed ID: 12239911 [TBL] [Abstract][Full Text] [Related]
11. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. Boyd CA; Benarroch-Gampel J; Sheffield KM; Cooksley CD; Riall TS J Surg Res; 2012 May; 174(1):12-9. PubMed ID: 21816433 [TBL] [Abstract][Full Text] [Related]
12. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Kardon DE; Thompson LD; Przygodzki RM; Heffess CS Mod Pathol; 2001 May; 14(5):443-51. PubMed ID: 11353055 [TBL] [Abstract][Full Text] [Related]
13. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing. Ma H; Song B; Guo S; Li G; Jin G Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074 [TBL] [Abstract][Full Text] [Related]
14. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets. Silvestris N; Brunetti O; Pinto R; Petriella D; Argentiero A; Fucci L; Tommasi S; Danza K; De Summa S Expert Opin Ther Targets; 2018 May; 22(5):453-461. PubMed ID: 29561217 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. Hsu JT; Chen HM; Wu RC; Yeh CN; Yeh TS; Hwang TL; Jan YY; Chen MF World J Surg Oncol; 2008 Sep; 6():95. PubMed ID: 18764955 [TBL] [Abstract][Full Text] [Related]
17. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. Zhao X; Li H; Lyu S; Zhai J; Ji Z; Zhang Z; Zhang X; Liu Z; Wang H; Xu J; Fan H; Kou J; Li L; Lang R; He Q Int J Biol Sci; 2021; 17(10):2590-2605. PubMed ID: 34326696 [TBL] [Abstract][Full Text] [Related]
18. Dissecting the presence of malignant squamous cells in pancreatic cytopathology: A case series. Sydney GI; Ioakim KJ; Sergentanis TN; Tsiotos GG; Kyriakidou V; Sepsa A; Theocharis S; Salla C; Nikas I Diagn Cytopathol; 2019 Dec; 47(12):1287-1292. PubMed ID: 31407529 [TBL] [Abstract][Full Text] [Related]
19. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder. Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889 [TBL] [Abstract][Full Text] [Related]
20. [A clinical series of 80 patients with adenosquamous carcinoma of pancreas]. Song B; Liu X; Ma H; Ji W; Shao C; Hu X; Jin G Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):658-61. PubMed ID: 25410777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]